Ivan King

2.0k citations

39 papers · 1.6k indexed · h-index 18

Impact in

Biotechnology top 0.2%
- Cancer Research and Treatments
Genetics top 5%
- Virus-based gene therapy research

Papers in ⓘ

Biotechnology 14
- Cancer Research and Treatments 13
Pharmaceutical Science 3

Co-authors: David Bermudes (11 shared papers)Li-Mou Zheng (8 shared papers)Stanley L. Lin (6 shared papers)Martina Ittensohn (5 shared papers)Mario Sznol (3 shared papers)Trung Bao Le (4 shared papers)Xiang Luo (4 shared papers)K. Brooks Low (3 shared papers)
Journals: Bioorganic & Medicinal Chemistry Letters (4 papers)Clinical Cancer Research (2 papers)Leukemia Research (2 papers)Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics (2 papers)Journal of Clinical Oncology (2 papers)
Partner nations: United States Australia United Kingdom

In The Last Decade

Ivan King

38 papers receiving 1.6k citations

Peers

Countries citing papers authored by Ivan King

Since Specialization

Citations

This map shows the geographic impact of Ivan King's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ivan King with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ivan King more than expected).

Fields of papers citing papers by Ivan King

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ivan King. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ivan King. The network helps show where Ivan King may publish in the future.

Co-authors

The 25 scholars most cited alongside Ivan King, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Ivan King Line = papers co-authored together Ivan King links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 39 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Lipid A mutant Salmonella with suppressed virulence and TNFα induction retain tumor-targeting in vivo Nature Biotechnology ·K. Brooks Low, Martina Ittensohn, Trung Bao Le, James T. Platt, Stefano Sodi, Max S. Amoss, Olivia Ash, Ellen P. Carmichael, Ashok K. Chakraborty, Jessica Fischer, Stanley L. Lin, Xiang Luo, Samuel I. Miller, Li-Mou Zheng, Ivan King, John M. Pawelek, David Bermudes	1999	407
2	Use of preferentially replicating bacteria for the treatment of cancer Journal of Clinical Investigation ·Mario Sznol, Stanley L. Lin, David Bermudes, Li-Mou Zheng, Ivan King	2000	139
3	Systemic Administration of an Attenuated, Tumor-TargetingSalmonella typhimuriumto Dogs with Spontaneous Neoplasia: Phase I Evaluation Clinical Cancer Research ·Douglas H. Thamm, Ilene D. Kurzman, Ivan King, Zujin Li, Mario Sznol, Richard R. Dubielzig, David M. Vail, E. Gregory MacEwen	2005	137
4	Tumor-Targeted Salmonella Expressing Cytosine Deaminase as an Anticancer Agent Human Gene Therapy ·Ivan King, David Bermudes, Stanley L. Lin, Michael F. Belcourt, Jeremy A. Pike, Kimberly Troy, Trung Bao Le, Martina Ittensohn, John Mao, Wenshang Lang, Jacob D. Runyan, Xiang Luo, Zujin Li, Li-Mou Zheng	2002	101
5	Antitumor Effect of VNP20009, an Attenuated *Salmonella, in Murine Tumor Models Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics* ·Xiaobo Luo, Zeying Li, Stanley L. Lin, Trung Bao Le, Martina Ittensohn, David Bermudes, J.D. Runyab, S-y. Shen, Jiahong Chen, Ivan King, L-m. Zheng	2001	94
6	Construction of VNP20009: A Novel, Genetically Stable Antibiotic-Sensitive Strain of Tumor-Targeting Salmonella for Parenteral Administration in Humans Humana Press eBooks ·K. Brooks Low, Martina Ittensohn, Xiang Luo, Li-Mou Zheng, Ivan King, John M. Pawelek, David Bermudes	2004	82
7	Attenuated Salmonella Targets Prodrug Activating Enzyme Carboxypeptidase G2 to Mouse Melanoma and Human Breast and Colon Carcinomas for Effective Suicide Gene Therapy Clinical Cancer Research ·Frank Friedlos, Panos Lehouritis, Lesley Ogilvie, Douglas Hedley, Lawrence Davies, David Bermudes, Ivan King, Jan Martin, Richard Marais, Caroline J. Springer	2008	76
8	Syntheses and Antitumor Activities of Potent Inhibitors of Ribonucleotide Reductase: 3-Amino-4-Methylpyridine-2-Carboxaldehyde-Thiosemicarbazone (3-Amp), 3-Amino-Pyridine-2-Carboxaldehyde-Thiosemicarbazone (3-Ap) and its Water-Soluble Prodrugs Current Medicinal Chemistry ·Jun Li, Bentham Science Publisher Li-mou Zheng, Ivan King, Terrence W. Doyle, Shu‐Hui Chen	2001	74
9	Tumor Amplified Protein Expression Therapy: *Salmonella* as a Tumor-Selective Protein Delivery Vector Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics ·L-m. Zheng, Xiaobo Luo, Ming Feng, Z. Li, Trung Bao Le, Martina Ittensohn, Mark D. TrailSmith, David Bermudes, Stanley L. Lin, Ivan King	2001	59
10	Characterization of the Antiviral Effect of 2′,3′-Dideoxy-2′, 3′-Didehydro-β-l-5-Fluorocytidine in the Duck Hepatitis B Virus Infection Model Antimicrobial Agents and Chemotherapy ·Franck Le Guerhier, Christian Pichoud, Sylviane Guérret, Michèle Chevallier, Catherine Jamard, O. Hantz, Xiuyan Li, Shuhui Chen, Ivan King, Christian Trépo, Yung‐Chi Cheng, Fabien Zoulim	2000	59
11	Live bacteria as anticancer agents and tumor-selective protein delivery vectors. PubMed ·David Bermudes, Li-Mou Zheng, Ivan King	2002	50
12	Triapine and cytarabine is an active combination in patients with acute leukemia or myelodysplastic syndrome Leukemia Research ·Karen Yee, Jörge E. Cortes, Alessandra Ferrajoli, Guillermo Garcia‐Manero, Srđan Verstovšek, William G. Wierda, Deborah A. Thomas, Stefan Faderl, Ivan King, Susan O’Brien, Sima Jeha, Michael Andreeff, Ann Cahill, Mario Sznol, Francis J. Giles	2006	41
13	A novel class of antitumor metabolites from the fungus Nattrassia Mangiferae Tetrahedron Letters ·Min Chu, Imbi Truumees, Mahesh Patel, Vincent P. Gullo, C H Blood, Ivan King, Jin-Keon Pai, Mohindar S. Puar	1994	41
14	A sensitive method to quantify the terminal differentiation of cultured epidermal cells Experimental Cell Research ·Ivan King, Sharon L. Mella, Alan C. Sartorelli	1986	38
15	The relationship between epidermal growth factor receptors and the terminal differentiation of A431 carcinoma cells Biochemical and Biophysical Research Communications ·Ivan King, Alan C. Sartorelli	1986	33
16	Tumor-Targeted Salmonella typhimurium Overexpressing Cytosine Deaminase: A Novel, Tumor-Selective Therapy Methods in molecular biology ·Ivan King, Martina Itterson, David Bermudes	2009	21
17	Comparative Evaluation of the Acute Toxic Effects in Monkeys, Pigs and Mice of a Genetically Engineered Salmonella Strain (VNP20009) Being Developed as an Antitumor Agent International Journal of Toxicology ·King C. Lee, Li-Mou Zheng, Xiang Luo, Caroline Clairmont, Jessica Fischer, D. Margitich, John C. Turnier, Bijan Almassian, David Bermudes, Ivan King	2000	20
18	Marine sponge bis(indole) alkaloids that displace ligand binding to α1 adrenergic receptors Bioorganic & Medicinal Chemistry Letters ·David W. Phife, Robert Ramos, Ming Feng, Ivan King, Sarath P. Gunasekera, Amy E. Wright, Mahesh Patel, Jonathan A. Pachter, Stephen J. Coval	1996	19
19	Synthesis and comparative evaluation of two antiviral agents: β-l-Fd4C and β-d-Fd4C Bioorganic & Medicinal Chemistry Letters ·Shu‐Hui Chen, Stanley L. Lin, Ivan King, Tracy Spinka, Ginger E. Dutschman, Elizabeth A. Gullen, Yung‐Chi Cheng, Terrence W. Doyle	1998	16
20	Tumour-SelectiveSalmonella-BasedCancer Therapy Biotechnology and Genetic Engineering Reviews ·David Bermudes, K. Brooks Low, John M. Pawelek, Ming Feng, Michael F. Belcourt, Li-Mou Zheng, Ivan King	2001	16

About Ivan King

Ivan King is a scholar working on Biotechnology, Pharmaceutical Science, Virology, Oncology and Molecular Biology, having authored 39 papers that have together received 1.6k indexed citations. Recurring topics across this work include Cancer Research and Treatments (13 papers), Nanoplatforms for cancer theranostics (8 papers), Virus-based gene therapy research (6 papers), RNA Interference and Gene Delivery (4 papers), Cancer therapeutics and mechanisms (4 papers), Glycosylation and Glycoproteins Research (4 papers), HIV/AIDS drug development and treatment (4 papers) and Protein Degradation and Inhibitors (3 papers). The work is most often cited by research in Biotechnology (1.1k citations), Genetics (601 citations), Biomedical Engineering (730 citations), Ecology (235 citations) and Endocrinology (45 citations). Ivan King has collaborated with scholars based in United States, Australia and United Kingdom. Frequent co-authors include David Bermudes, Li-Mou Zheng, Stanley L. Lin, Martina Ittensohn, Mario Sznol, Trung Bao Le, Xiang Luo, K. Brooks Low, John M. Pawelek and Alan C. Sartorelli. Their work appears in journals such as Bioorganic & Medicinal Chemistry Letters, Clinical Cancer Research, Leukemia Research, Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics and Journal of Clinical Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact